Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

AC Immune Aktie: FDA genehmigt US-Studien für ACI-7104Photo, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
AC Immune Aktie: FDA genehmigt US-Studien für ACI-7104

Das Biopharma-Unternehmen AC Immune hat einen entscheidenden regulatorischen Fortschritt bei der Entwicklung seines Impfstoffkandidaten…

Der Beitrag AC Immune Aktie: FDA genehmigt US-Studien für

Can AWR Continue Raising Dividends for Long-Term Shareholders?
Can AWR Continue Raising Dividends for Long-Term Shareholders?

American States Water Company AWR continues to reward shareholders through regular dividend payments and consistent annual dividend increases. Its long-standing dividend record reflects the strength

Can BMY's First CELMoD Approval Support Its Growth Strategy?
Can BMY's First CELMoD Approval Support Its Growth Strategy?

Bristol Myers Squibb BMY recently announced that the FDA has granted accelerated approval to iberdomide in combination with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd).

The regimen

Synopsys (SNPS) Gains As Market Dips: What You Should Know
Synopsys (SNPS) Gains As Market Dips: What You Should Know

In the latest close session, Synopsys (SNPS) was up +2.37% at $421.50. The stock exceeded the S&P 500, which registered a loss of 0.17% for the day. At the same time, the Dow lost 0.2%, and the

Pegasystems Touts Governed AI Workflows, Token-Free Pricing at Oppenheimer ConferencePhoto, wide shot, wide-angle lens, soft focus,  IT consulting firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-uhXP0RHYYxDepjmHeSp1K8bF.png?st=2023-05-07T15%3A26%3A44Z&se=2023-05-07T17%3A26%3A44Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-07T16%3A18%3A55Z&ske=2023-05-08T16%3A18%3A55Z&sks=b&skv=2021-08-06&sig=4pcJOd8aEI1799liUV13F4ElqO7e4RZy8sa1PEeeNZA%3D
Pegasystems Touts Governed AI Workflows, Token-Free Pricing at Oppenheimer Conference

Key Points

UBS Aktie: 153 Millionen US-Dollar US-StrafenPhoto, wide shot, wide-angle lens,  Bank, sunset photo at golden hour, photo by Art Wolfe: https://img.theapi.app/temp/3aa597ca-f944-4a9b-bf8d-3071f3b5a5c9.png
UBS Aktie: 153 Millionen US-Dollar US-Strafen

UBS steckt zwischen zwei ungelösten Regulierungsfronten fest: US-Behörden verhängten Anfang August Strafen von insgesamt…

Der Beitrag UBS Aktie: 153 Millionen US-Dollar US-Strafen erschien zuerst

NeuroPace Faces an IGE Delay: What the FDA Setback Means for Growth
NeuroPace Faces an IGE Delay: What the FDA Setback Means for Growth

NeuroPace, Inc. NPCE has hit a regulatory delay in its bid to expand the RNS System into idiopathic generalized epilepsy, or IGE. The FDA’s July 2026 response pushes out a potential growth catalyst

C3.ai, Inc. (AI) Registers a Bigger Fall Than the Market: Important Facts to NotePhoto, wide shot, wide-angle lens,  Computer hardware manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.theapi.app/temp/32e7a10f-efd0-424a-861f-2f3e0bb7ce02.png
C3.ai, Inc. (AI) Registers a Bigger Fall Than the Market: Important Facts to Note

In the latest trading session, C3.ai, Inc. (AI) closed at $9.70, marking a -2.32% move from the previous day. This change lagged the S&P 500's 0.52% loss on the day. Elsewhere, the Dow saw a

KB Home (KBH) Registers a Bigger Fall Than the Market: Important Facts to Note
KB Home (KBH) Registers a Bigger Fall Than the Market: Important Facts to Note

KB Home (KBH) closed the most recent trading day at $55.44, moving -1.11% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.52%. Meanwhile, the Dow

Ulta Beauty (ULTA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Ulta Beauty (ULTA) Sees a More Significant Dip Than Broader Market: Some Facts to Know

In the latest close session, Ulta Beauty (ULTA) was down 3.42% at $493.27. The stock trailed the S&P 500, which registered a daily loss of 0.52%. Elsewhere, the Dow lost 0.51%, while the tech-heavy

Here's Why PepsiCo (PEP) Fell More Than Broader Market
Here's Why PepsiCo (PEP) Fell More Than Broader Market

In the latest close session, PepsiCo (PEP) was down 1.82% at $138.23. The stock fell short of the S&P 500, which registered a loss of 0.52% for the day. At the same time, the Dow lost 0.51%, and the

Here's Why Chewy (CHWY) Fell More Than Broader Market
Here's Why Chewy (CHWY) Fell More Than Broader Market

Chewy (CHWY) closed at $22.13 in the latest trading session, marking a -1.29% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.52%. Meanwhile, the Dow lost

NIO Inc. (NIO) Advances While Market Declines: Some Information for Investors
NIO Inc. (NIO) Advances While Market Declines: Some Information for Investors

NIO Inc. (NIO) closed at $4.60 in the latest trading session, marking a +1.77% move from the prior day. The stock outperformed the S&P 500, which registered a daily loss of 0.52%. On the other hand

Why Intuit (INTU) Dipped More Than Broader Market Today
Why Intuit (INTU) Dipped More Than Broader Market Today

Intuit (INTU) closed the most recent trading day at $335.60, moving -2.91% from the previous trading session. The stock fell short of the S&P 500, which registered a loss of 0.52% for the day. At

Workday (WDAY) Declines More Than Market: Some Information for Investors
Workday (WDAY) Declines More Than Market: Some Information for Investors

Workday (WDAY) closed the most recent trading day at $191.18, moving -3.77% from the previous trading session. The stock trailed the S&P 500, which registered a daily loss of 0.52%. Elsewhere, the

4 Refining Stocks to Buy as Gas Prices Top $4 a Gallon: https://staticx-tuner.zacks.com/images/articles/main/f1/149711.webp
4 Refining Stocks to Buy as Gas Prices Top $4 a Gallon

U.S. motorists are once again feeling the pinch at the pump, with the average retail price of regular gasoline climbing above $4 per gallon. The U.S. Energy Information Administration (EIA) recently

Tilray Brands, Inc. (TLRY) Registers a Bigger Fall Than the Market: Important Facts to Note
Tilray Brands, Inc. (TLRY) Registers a Bigger Fall Than the Market: Important Facts to Note

Tilray Brands, Inc. (TLRY) closed the most recent trading day at $4.48, moving -4.07% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.52%. At the

HP (HPQ) Dips More Than Broader Market: What You Should Know
HP (HPQ) Dips More Than Broader Market: What You Should Know

In the latest trading session, HP (HPQ) closed at $29.40, marking a -2.36% move from the previous day. The stock trailed the S&P 500, which registered a daily loss of 0.52%. Elsewhere, the Dow lost

Dollar General (DG) Suffers a Larger Drop Than the General Market: Key Insights
Dollar General (DG) Suffers a Larger Drop Than the General Market: Key Insights

Dollar General (DG) ended the recent trading session at $120.08, demonstrating a -2.6% change from the preceding day's closing price. The stock fell short of the S&P 500, which registered a loss of

Tilray Medical begrüßt die positiven Entwicklungen im deutschen Rechtsrahmen für medizinisches Cannabis und setzt sich für dessen kontinuierliche Weiterentwicklung einPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Tilray Medical begrüßt die positiven Entwicklungen im deutschen Rechtsrahmen für medizinisches Cannabis und setzt sich für dessen kontinuierliche Weiterentwicklung ein

Als weltweit führender Anbieter von medizinischem Cannabis unterstützt Tilray Medical eine Weiterentwicklung der Regulierung, die das Vertrauen der Ärzteschaft stärkt, den Zugang der Patienten